Literature DB >> 18257968

Association of functional polymorphisms in NOS1 and NOS3 with loudness dependence of auditory evoked potentials.

Wolfram Kawohl1, Ina Giegling, Paraskevi Mavrogiorgou, Oliver Pogarell, Christoph Mulert, Hans-Jürgen Möller, Ulrich Hegerl, Dan Rujescu, Georg Juckel.   

Abstract

Nitric oxide (NO) is a gaseous molecule with neurotransmitter properties that is involved in numerous functions in the central nervous system (CNS), the vascular system and also in macrophages. Haplotypes of NOS1 and NOS3 genes have been shown to be associated with different psychiatric disorders such as schizophrenia and bipolar disorder. Therefore, the detection of other characteristics of nitrinergic transmission is desirable. Because nitrinergic functioning influences serotonergic transmission, a functional marker of the serotonergic transmission, the loudness dependence of auditory evoked potentials (LDAEP), can be assumed to be influenced by nitrinergic changes as well. In order to clarify the relationship between nitrinergic transmission and LDAEP, 95 healthy subjects (41 males, 54 females) underwent electrophysiological recording and blood drawing for genotyping of single nucleotide polymorphisms (SNPs) and haplotypes of the NOS1 and NOS3 genes. Interestingly, two functional SNPs in both NOS1 (G-84A_exon 1c promoter polymorphism) and NOS3 (Glu298Asp) were associated with lower LDAEP. Further studies are needed to fully clarify the relationship between nitrinergic transmission, LDAEP and complex disorders such as schizophrenia and affective disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18257968     DOI: 10.1017/S1461145708008420

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  7 in total

1.  Molecular profiling of reticular gigantocellularis neurons indicates that eNOS modulates environmentally dependent levels of arousal.

Authors:  Inna Tabansky; Yupu Liang; Maya Frankfurt; Martin A Daniels; Matthew Harrigan; Sarah Stern; Teresa A Milner; Rebecca Leshan; Rrezarta Rama; Tabea Moll; Jeffrey M Friedman; Joel N H Stern; Donald W Pfaff
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-02       Impact factor: 11.205

2.  Examination of the effect of acute levodopa administration on the loudness dependence of auditory evoked potentials (LDAEP) in humans.

Authors:  K Hitz; K Heekeren; C Obermann; T Huber; G Juckel; W Kawohl
Journal:  Psychopharmacology (Berl)       Date:  2011-11-26       Impact factor: 4.530

3.  Loudness- and time-dependence of auditory evoked potentials is blunted by the NMDA channel blocker MK-801.

Authors:  Tobias Teichert
Journal:  Psychiatry Res       Date:  2017-06-15       Impact factor: 3.222

4.  Genetic Association Analysis of NOS3 and Methamphetamine-Induced Psychosis Among Japanese.

Authors:  T Okochi; T Kishi; M Ikeda; T Kitajima; Y Kinoshita; K Kawashima; T Okumura; T Tsunoka; Y Fukuo; T Inada; M Yamada; N Uchimura; M Iyo; I Sora; N Ozaki; H Ujike; N Iwata
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

5.  Early Recognition of High Risk of Bipolar Disorder and Psychosis: An Overview of the ZInEP "Early Recognition" Study.

Authors:  Anastasia Theodoridou; Karsten Heekeren; Diane Dvorsky; Sibylle Metzler; Maurizia Franscini; Helene Haker; Wolfram Kawohl; Nicolas Rüsch; Susanne Walitza; Wulf Rössler
Journal:  Front Public Health       Date:  2014-10-01

6.  Cortical response variation with different sound pressure levels: a combined event-related potentials and FMRI study.

Authors:  Irene Neuner; Wolfram Kawohl; Jorge Arrubla; Tracy Warbrick; Konrad Hitz; Christine Wyss; Frank Boers; N Jon Shah
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

7.  The loudness dependence of auditory evoked potentials (LDAEP) as an indicator of serotonergic dysfunction in patients with predominant schizophrenic negative symptoms.

Authors:  Christine Wyss; Konrad Hitz; Michael P Hengartner; Anastasia Theodoridou; Caitriona Obermann; Idun Uhl; Patrik Roser; Edna Grünblatt; Erich Seifritz; Georg Juckel; Wolfram Kawohl
Journal:  PLoS One       Date:  2013-07-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.